Healthcare & Medical

SSAI Annual Congress and Swiss Autoimmune Liver Disease Meeting 2026

Name: SSAI Annual Congress and Swiss Autoimmune Liver Disease Meeting 2026
Start: 2026-08-27
End: 2026-08-28
Location: Palazzo dei Congressi Lugano

The SSAI Annual Congress and Swiss Autoimmune Liver Disease Meeting brings together professionals in immunology and related fields to discuss advances and research. The 2026 edition will be held in Lugano, Switzerland over two days at the end of August.

Visit the official site Sponsorship open

85Speakers

31Sponsors

31Exhibitors

167On the bill · sessions

64Companies · in total

§I

Speakers

Programmed at SSAI, in alphabetical order.

Ales Drobek

Epalinges

Alexander Eggel

Bern

Ana Alcaraz-Serna

Lausanne

Andreas Cerny

Lugano

Andreas Kremer

Zürich

Anne Dudeck

Magdeburg DE

Anne Hosmalin

Paris FR

Antonio Galante

Lugano

Bingjie Zhao

Davos Wolfgang

Camillo Ribi

Lausanne

Christina Weber

Zürich

Christine Bernsmeier

Basel

Christoph Hess

Basel

Claudia Mauri

London GB

Claudia Rizzi

Locarno

Daphne Mccarthy

Basel

Davide Robbiani

Bellinzona

Davide Salvioni

David Semela

St. Gallen

Eleonora de Martin

Villejuif FR

Elisa Sorrenti

Bellinzona

Elnaz Arjmand

Bern

§II

Agenda

Selected from 167 sessions on the bill.

09:45–09:55
Welcome to the Joint Meeting of SSAI and SASL – AILD
Plenary
09:45 – 10:00
Welcome to Lugano
Plenary
09:45 – 10:00 Thursday, 27.08.2026
Welcome to Lugano
Welcome to the Joint Meeting of SSAI and SASL – AILD
10:00–10:25
Antibody-selective treatment in autoimmunity
Plenary 1: B Cells in Autoimmunity
10:00 – 11:00
Plenary 1 – B Cells in Autoimmunity
10:00 – 11:00
Plenary 1: B Cells in Autoimmunity
Plenary
10:00 – 11:00 Thursday, 27.08.2026
Plenary 1 – B Cells in Autoimmunity
10:30–10:55
B cells across cancer and autoimmunity
Plenary 1: B Cells in Autoimmunity
11:30–11:55
Checkpoint Inhibitor–Induced Hepatotoxicity: Diagnosis and Management
Plenary 2: T Cells in Tolerance and Immunity

Intermission

Part the Second · For the Buyer

What does it mean when 64 companies show up, and 31 bet on three roles at once?

64 companies. 31 are betting more than once.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page, cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

Who's in the room

31All threespeak · spons · exh

0Sponsoringsponsor only

0Exhibitingexhibitor only

33Companies Speakingspeaker only

The Triple-Threat

ADR-AC GmbH·ALK-Abelló AG·Allergopharma·Association "Research for Life"·AstraZeneca·Beckman Coulter Life Sciences·Bencard AG·Biotest (Schweiz) AG·Careformance GmbH·CSL Behring AG·Euroimmun Schweiz AG·Gilead Sciences Switzerland Sàrl·GlaxoSmithKline AG·iQone Healthcare Switzerland (a Celltrion Company)·KalVista Pharmaceuticals Switzerland GmbH·MediService AG·Moderna Switzerland GmbH·Novartis Pharma Schweiz AG·Octapharma AG·Otsuka Pharmaceutical (Switzerland) GmbH·RUWAG Handels AG·Sanofi-Regeneron

Speakers by seniority

Other roles85100%

Of 85 on the bill · classified by free-text title

Most-represented companies

Sponsors by tier

unspecified31

100% of 31

SSAI Annual Congress and Swiss Autoimmune Liver Disease Meeting 2026

Welcome to the Joint Meeting of SSAI and SASL – AILD

Welcome to Lugano

Welcome to Lugano

Antibody-selective treatment in autoimmunity

Plenary 1 – B Cells in Autoimmunity

Plenary 1: B Cells in Autoimmunity

Plenary 1 – B Cells in Autoimmunity

B cells across cancer and autoimmunity

Checkpoint Inhibitor–Induced Hepatotoxicity: Diagnosis and Management

64 companies. 31 are betting more than once.